Rong Deng - Genentech | 人才画像

基本信息

浏览量：25

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 75 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

A Novel Step-Up Dosage Regimen for Enhancing the Benefit-to-Risk Ratio of Mosunetuzumab in Relapsed or Refractory Follicular Lymphoma

Chi-Chung Li,Brendan Bender,Justin Wilkins,Feifei Li,David C. Turner,Bei Wang,Rong Deng,Shweta Vadhavkar,Zao Li,Antonia Kwan, Huang,Kun Peng,Elicia Penuel,Ling-Yuh Huw,Pascal Chanu,Chunze Li,Shen Yin,Michael C. Wei

CLINICAL PHARMACOLOGY & THERAPEUTICS (2024)

引用0浏览0WOS引用

Clinical Pharmacology Strategies to Accelerate the Development of Polatuzumab Vedotin and Summary of Key Findings

Michael Z. Liao,Dan Lu,Tong Lu,Leonid Gibiansky,Rong Deng,Divya Samineni,Randall Dere, Andy Lin,Jamie Hirata,Ben-Quan Shen,Donglu Zhang,Dongwei Li,Chunze Li,Dale Miles

Advanced Drug Delivery Reviews (2024): 115193-115193

引用0浏览0WOS引用

Population Pharmacokinetics and CD20 Binding Dynamics for Mosunetuzumab in Relapsed/refractory B‐cell Non‐hodgkin Lymphoma

Brendan Bender,Chi-Chung Li,Mathilde Marchand,David C. Turner,Feifei Li,Shweta Vadhavkar,Bei Wang,Rong Deng,James Lu, Jin,Chunze Li,Shen Yin,Michael Wei,Pascal Chanu

CTS-CLINICAL AND TRANSLATIONAL SCIENCEno. 6 (2024)

引用0浏览0WOS引用

Population Pharmacokinetics and Exposure–response Analyses of Polatuzumab Vedotin in Patients with Previously Untreated DLBCL from the POLARIX Study

Rong Deng,Leonid Gibiansky,Tong Lu,Christopher R. Flowers,Laurie H. Sehn, Qi Liu,Priya Agarwal,Michael Z. Liao,Randall Dere,Calvin Lee,Gabriel Man,Jamie Hirata,Chunze Li,Dale Miles

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGYno. 6 (2024): 1055-1066

引用0浏览0WOS引用

Assessment of CYP3A‐mediated Drug Interaction Via Cytokine (IL‐6) Elevation for Mosunetuzumab Using Physiologically‐based Pharmacokinetic Modeling

Yuan Chen,Fang Ma,Nicholas Jones,Rong Deng,Chunze Li,Chi-Chung Li

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGYno. 2 (2024): 234-246

引用0浏览0WOS引用

Venetoclax Clinical Pharmacokinetics after Administration of Crushed, Ground or Whole Tablets

Samaneh Alaei, Yamin Wang, Yueli Liu, Julia Schiele,Rong Deng, Danielle Shiller,Patrick Marroum,Rajeev Menon,Ahmed Hamed Salem

CLINICAL THERAPEUTICSno. 10 (2024): 752-758

引用0浏览0WOS引用

Pooled Population Pharmacokinetic Analyses of Venetoclax in Patients Across Indications and Healthy Subjects from Phase 1, 2, and 3 Clinical Trials

Jingqi Q. X. Gong,Ahmed A. Suleiman,Rajeev Menon,Rong Deng,Sven Mensing,Ahmed Hamed Salem

JOURNAL OF CLINICAL PHARMACOLOGY（2023）

引用1浏览0WOS引用

Population Pharmacokinetics of Tenecteplase in Patients with Acute Myocardial Infarction and Application to Patients with Acute Ischemic Stroke

Fei Tang,Jurgen Langenhorst,Steve Dang,Nastya Kassir,Ryan Owen,Barbara Purdon,Mats O. O. Magnusson,Rong Deng

JOURNAL OF CLINICAL PHARMACOLOGY（2023）

引用1浏览0WOS引用

Ethnic Sensitivity Assessment: Polatuzumab Vedotin Pharmacokinetics in Asian and Non‐asian Patients with Previously Untreated Diffuse Large B‐cell Lymphoma in POLARIX

Michael Z. Liao,Rong Deng,Leonid Gibiansky,Tong Lu,Priya Agarwal,Randall Dere,Calvin Lee,Jamie Hirata,Charles Herbaux,Gilles Salles,Chunze Li,Dale Miles

CTS-CLINICAL AND TRANSLATIONAL SCIENCEno. 12 (2023): 2744-2755

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn